Evaluation of a novel particle-based assay for detection of autoantibodies in idiopathic inflammatory myopathies

Journal of Immunological Methods - Tập 474 - Trang 112661 - 2019
I. Cavazzana1, M. Richards2, C. Bentow3, A. Seaman4, M. Fredi1,5, M.G. Giudizi6, B. Palterer6, F. Pratesi7, P. Migliorini7, F. Franceschini1,5, M. Satoh8, A. Ceribelli9, M. Mahler2
1Rheumatology Unit, ASST Spedali Civili, Brescia, Italy
2Inova Diagnostics, Inc., San Diego, CA, USA
3INOVA Diagnostics, INC., San Diego, CA, USA
4INOVA Diagnostics Inc., San Diego, CA, USA
5Rheumatology Unit and Chair, Department of Clinical and Experimental Science, University of Brescia, Brescia, Italy
6Department of Clinical and Experimental Medicine, Unit of Allergology and Clinical Immunology, University of Florence, Florence, Italy
7Department of Clincial and Experiment Medicine, University of Pisa, Pisa, Italy
8Department of Clinical Nursing, University of Occupational and Environmental Health, Kitakyushu, Japan
9BIOMETRA Department, Humanitas Clinical and Research Center - IRCCS, Rozzano, Italy

Tài liệu tham khảo

Aggarwal, 2015, Anti-signal recognition particle autoantibody ELISA validation and clinical associations, Rheumatology. (Oxford), 54, 1194, 10.1093/rheumatology/keu436

Bohan, 1975, Polymyositis and dermatomyositis (first of two parts), N. Engl. J. Med., 292, 344, 10.1056/NEJM197502132920706

Bohan, 1975, Polymyositis and dermatomyositis (second of two parts), N. Engl. J. Med., 292, 403, 10.1056/NEJM197502202920807

Bottai, 2017, EULAR/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a methodology report. RMD, Open., e000507, 3

Cavazzana, 2016, Testing for myositis specific autoantibodies: Comparison between line blot and immunoprecipitation assays in 57 myositis sera, J. Immunol. Methods, 433, 1, 10.1016/j.jim.2016.02.017

Espinosa-Ortega, 2019, Comparison of autoantibody specificities tested by a line blot assay and immunoprecipitation-based algorithm in patients with idiopathic inflammatory myopathies, Ann. Rheum. Dis., 78, 858, 10.1136/annrheumdis-2018-214690

Ghirardello, 2010, Diagnostic performance and validation of autoantibody testing in myositis by a commercial line blot assay, Rheumatology. (Oxford), 49, 2370, 10.1093/rheumatology/keq281

Imbert-Masseau, 2003, Antisynthetase syndrome, Joint Bone Spine, 70, 161, 10.1016/S1297-319X(03)00012-5

Lundberg, 2017, 2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups, Arthritis Rheumatol, 69, 2271, 10.1002/art.40320

Lundberg, 2017, 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups, Ann. Rheum. Dis., 76, 1955, 10.1136/annrheumdis-2017-211468

Lundberg, 2018, Response to: ‘Performance of the 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies in clinical practice’ by Hocevar et al, Ann. Rheum. Dis., 77, e91, 10.1136/annrheumdis-2017-212786

Lundberg, 2018, Classification of myositis, Nat. Rev. Rheumatol, 14, 269, 10.1038/nrrheum.2018.41

Mahler, 2019, Comparison of Three Immunoassays for the Detection of Myositis Specific Antibodies, Front Immunol., 10, 848, 10.3389/fimmu.2019.00848

Mahler, 2018, Detection of myositis-specific antibodies: additional notes, Ann. Rheum. Dis., 78, e45, 10.1136/annrheumdis-2018-213153

Mahler, 2014, Current concepts and future directions for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies, J. Immunol. Res., 315, 179

Malaviya, 2017, 2017 EULAR/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: little emphasis on autoantibodies, why?, Ann. Rheum. Dis., 77, e77, 10.1136/annrheumdis-2017-212701

Mariampillai, 2018, Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies, JAMA Neurol., 75, 1528, 10.1001/jamaneurol.2018.2598

McHugh, 2018, Autoantibodies in myositis, Nat. Rev. Rheumatol, 14, 290, 10.1038/nrrheum.2018.56

Picard, 2016, Heterogeneous clinical spectrum of anti-SRP myositis and importance of the methods of detection of anti-SRP autoantibodies: a multicentric study, Immunol. Res., 64, 677, 10.1007/s12026-015-8774-6

Richards, 2019, Autoantibodies to Mi-2 alpha and Mi-2 beta in patients with idiopathic inflammatory myopathy, Rheumatology, 76, 867

Ronnelid, 2009, Use of a commercial line blot assay as a screening test for autoantibodies in inflammatory myopathies, Autoimmun. Rev., 9, 58, 10.1016/j.autrev.2009.03.005

Satoh, 2017, A comprehensive overview on myositis-specific antibodies: new and old biomarkers in idiopathic inflammatory myopathy, Clin Rev. Allergy Immunol., 52, 10.1007/s12016-015-8510-y

Suzuki, 2015, Inflammatory myopathy with anti-signal recognition particle antibodies: case series of 100 patients, Orphanet. J. Rare. Dis., 10, 61, 10.1186/s13023-015-0277-y

Vulsteke, 2019, Detection of myositis-specific antibodies, Ann. Rheum. Dis., 78, e7, 10.1136/annrheumdis-2017-212915

Vulsteke, 2019, Autoantibodies at the center of (sub) classification-issues of detection, JAMA Neurol., 76, 867, 10.1001/jamaneurol.2019.0440

Thông tin
Thông tin xuất bản

Journal of Immunological Methods

Tập 474

112661

Thông tin tác giả